NCT00210938View on ClinicalTrials.gov

Doripenem in the Treatment of Complicated Intra-Abdominal Infections

PHASE3CompletedINTERVENTIONAL
Enrollment

478

Participants

Timeline

Start Date

March 31, 2004

Study Completion Date

January 31, 2006

Conditions
Bacterial Infections and MycosesAppendicitisCholecystitisPancreatitisPeritonitis
Interventions
DRUG

Doripenem

Sponsors
All Listed Sponsors
collaborator

Peninsula Pharmaceuticals, Inc.

INDUSTRY

lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY